TRANSGENE BIOTEK LTD. Share price

TRABI

Small Cap | Healthcare
₹2.36
-0.08 (-3.27%)
‌
Stock price as on 22 Oct 2026 at 15:29 PM

Transgene biotek ltd. share price today

Transgene Biotek Ltd. share price is currently at ₹2.36, which is down by ₹-0.08 from its previous closing. Today the stock has fluctuated between ₹2....

Transgene Biotek Ltd. stock performance

Today’s low

₹2.3

Today’s high

₹2.68

₹2.36

52 week low

₹1.83

52 week high

₹4.34

₹2.36
Open
₹2.45
Previous close
₹2.44
Share volume
11,220
Total traded value (Lakh)
₹0.26
Upper circuit
₹2.92
Lower circuit
₹1.96

Transgene Biotek Ltd. fundamentals

Market cap (Cr)
₹17.90
P/E ratio (TTM)
-11.62
Book value per share
-₹1.21
Beta
1.16
Return on equity
0%
Earnings per share (TTM)
₹0.00
Dividend yield
0%
Net profit/quarter (Cr)
-₹0.39

Transgene Biotek Ltd. technical summary

₹2.36
-3.27 ▼
16
Bearish
0
Bullish
5 Day2.5
10 Day2.5
12 Day2.5
20 Day2.6
26 Day2.6
50 Day2.7
100 Day2.8
200 Day3
5 Day2.5
10 Day2.5
12 Day2.5
20 Day2.5
26 Day2.6
50 Day2.7
100 Day2.9
200 Day2.8

2.48

PIVOT

First support
₹2.36
First resistance
₹2.61
Second support
₹2.23
Second resistance
₹2.73
Third support
₹2.11
Third resistance
₹2.86
RSI
44.94
ADX
17.87
MACD
-0.06
Williams % R
-59.21
Commodity Channel Index (CCI)
-50.45
Date
19 Oct 2026
Same day
9,612
Week
11,728
Month
22,194
1 year
1.16
3 years
0.66
Over 1 month
-7.77%▼
Over 1 year
-41.41%▼
Over 3 months
-16.44%▼
Over 3 years
-15.03%▼
Over 6 months
-19.41%▼
Over 6 years
-8.81%▼

Investment Returns

Over 1 Month7.77%▼
Over 3 Months16.44%▼
Over 6 Months19.41%▼
Over 1 Year41.41%▼

Transgene Biotek Ltd. Shareholding pattern


Public
76.36%
Promoter holdings
23.63%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Dr K Koteswara Rao

1,52,11,902 (21.89%)

Shareholding of Promoter and Promoter Group

Kollipara Nirmala

11,92,000 (1.72%)

Shareholding of Promoter and Promoter Group

Kollipara Srinivas

24,000 (0.03%)

Shareholding of Promoter and Promoter Group

Any Other(other Shr Off Family)

100 (0%)

Public Shareholding

Promoter sharesShareCategory
Dr K Koteswara Rao1,52,11,902 (21.89%)Shareholding of Promoter and Promoter Group
Kollipara Nirmala11,92,000 (1.72%)Shareholding of Promoter and Promoter Group
Kollipara Srinivas24,000 (0.03%)Shareholding of Promoter and Promoter Group
Any Other(other Shr Off Family)100 (0%)Public Shareholding

About TRANSGENE BIOTEK LTD.

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc. The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company i

Parent Organisation

Indian Private

NSE Symbol

TRABI

Founded

1990

TRANSGENE BIOTEK LTD. CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

REPL

RUDRABHISHEK ENTERP LTD

78.69
+13.11 (+19.99%)
OPTIFIN

OPTIMUS FINANCE LIMITED

16.88
+2.81 (+19.97%)
OPTIFIN

OPTIMUS FINANCE LTD.

16.89
+2.8 (+19.87%)
KEYFINSERV

KEYNOTE FINANCIAL SERVICES LIM

262.8
+42.55 (+19.32%)
View all

Top gainers

BAJFINANCE

BAJAJ FINANCE LIMITED

942.1
+16.10 (+1.74%)
CIPLA

CIPLA LTD

1330.9
+16.90 (+1.29%)
ULTRACEMCO

ULTRATECH CEMENT LIMITED

10958
+109.00 (+1.00%)
ICICIBANK

ICICI BANK LTD.

1398.5
+13.50 (+0.97%)
View all

Top losers

NESTLEIND

NESTLE INDIA LIMITED

1189.9
-34.00 (-2.78%)
ETERNAL

ETERNAL LIMITED

304.45
-7.90 (-2.53%)
HDFCLIFE

HDFC LIFE INS CO LTD

528.35
-11.30 (-2.09%)
TMPV

TATA MOTORS PASS VEH LTD

270
-5.70 (-2.07%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)